Stocks › HURA

TuHURA Biosciences, Inc./NV

HURA·Nasdaq·United States United States·USD
$1.25
-0.11 (-8.09%)
Close · Nov 20, 2026 · Close Prices from Tiingo.com
HURA
TuHURA Biosciences, Inc./NV · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
HURAS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair

Congressional Trades

Recent trades of HURA by members of U.S. Congress · 3 on record
All congressional trades →
PoliticianStockTypeFiledTraded
Laurel M. LeeLaurel M. LeeHouse · R · FL HURATuHURA Biosciences, Inc./NV · Stock Purchase
$50,001 - $100,000
Aug 9, 2025 Jul 13, 2025 Filing ↗
Laurel M. LeeLaurel M. LeeHouse · R · FL HURATuHURA Biosciences, Inc./NV · Stock Purchase
$1,001 - $15,000
Jan 7, 2025 Nov 25, 2024 Filing ↗
Laurel M. LeeLaurel M. LeeHouse · R · FL HURATuHURA Biosciences, Inc./NV · Cash Purchase
$100,001 - $250,000
May 25, 2024 May 6, 2024 Filing ↗

Whale Activity

Position changes in HURA reported for 2026-09-30 by 93 institutional filers
Increased: 12New: 7Held: 17Decreased: 38Closed: 17No prior filing: 2
  • Increased12
  • New7
  • Held17
  • Decreased38
  • Closed17
  • No prior filing2
FilerSharesValueChange
VANGUARD CAPITAL MANAGEMENT LLC2.3M$4.7Mdecreased
BlackRock, Inc.588.2K$1.2Mdecreased
FIFTH THIRD BANCORP521.6K$1.1Mnew
GEODE CAPITAL MANAGEMENT, LLC472.8K$993Kdecreased
MILLENNIUM MANAGEMENT LLC281.3K$591Kdecreased
VANGUARD FIDUCIARY TRUST CO275.6K$579Kincreased
BANK OF AMERICA CORP /DE/246.8K$518Kincreased
STATE STREET CORP192.6K$404Kincreased
Apollon Wealth Management, LLC158.1K$332Kincreased
Bank of New York Mellon Corp111.7K$234Kdecreased
AQR CAPITAL MANAGEMENT LLC110.9K$233Kdecreased
SUSQUEHANNA INTERNATIONAL GROUP, LLP106.7K$224Kincreased

Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.

Insider Trading

Net shares bought (+) or sold (−) on the open market by HURA insiders, by quarter · Form 4

No open-market insider buys or sells in the last two years.

Recent Insider Transactions

1 transactions on record · newest first
All insider activity →
InsiderTypeSharesPriceValueDate
Bianco James A.Chief Executive Officer · Director Gift −150.0K $0.00 $0 May 28, 2026 Form 4 ↗

Fund Holders

Mutual funds and ETFs holding HURA · SEC Form N-PORT
FundSharesValue% of fundAs of
VANGUARD TOTAL STOCK MARKET INDEX FUND
VANGUARD INDEX FUNDS
1.7M$4.1M0.00%Jun 30, 2026
VANGUARD EXTENDED MARKET INDEX FUND
VANGUARD INDEX FUNDS
447.7K$1.0M0.00%Jun 30, 2026
Fidelity Small Cap Index Fund
Fidelity Salem Street Trust
428.5K$960K0.00%Apr 30, 2026
VANGUARD RUSSELL 2000 INDEX FUND
VANGUARD SCOTTSDALE FUNDS
219.3K$496K0.00%May 31, 2026
Fidelity Extended Market Index Fund
Fidelity Concord Street Trust
213.0K$454K0.00%Aug 31, 2026
iShares Micro-Cap ETF
iShares Trust
163.7K$383K0.03%Jun 30, 2026
Schwab Small-Cap Index Fund
SCHWAB CAPITAL TRUST
98.9K$222K0.00%Apr 30, 2026
Fidelity Total Market Index Fund
Fidelity Concord Street Trust
76.3K$162K0.00%Aug 31, 2026
Fidelity Series Total Market Index Fund
Fidelity Concord Street Trust
64.8K$138K0.00%Aug 31, 2026
VANGUARD RUSSELL 2000 GROWTH INDEX FUND
VANGUARD SCOTTSDALE FUNDS
40.0K$90K0.01%May 31, 2026

Mutual funds and ETFs whose N-PORT filings list HURA's shares (CUSIP 898920103), each fund at its latest report since Apr 21, 2026, largest positions first. Bonds, options and short positions are left out.

Activist & Passive Stakes

Schedule 13D / 13G beneficial-ownership filings
  • James A. Bianco, M.D.SCHEDULE 13D/A · activist (13D) · 3.1M shares4.6%
    Aug 28, 2026 · ↗
  • CA Patel F&F Investments, LLCSCHEDULE 13G/A · passive (13G) · 447.2K shares0.9%
    Aug 14, 2025 · ↗

Corporate Lobbying

Estimated quarterly lobbying spending reported under the LDA, filings naming TuHURA Biosciences, Inc./NV as client

No lobbying filings found naming TuHURA Biosciences, Inc./NV as the client.

Government Contracts

Federal awards to TuHURA Biosciences, Inc./NV · USAspending

No federal contract awards found for TuHURA Biosciences, Inc./NV.

U.S. Patents

Recent USPTO applications naming TuHURA Biosciences, Inc./NV

No USPTO patent applications found for TuHURA Biosciences, Inc./NV.

Annual Financials

From HURA's 10-K filings · XBRL
Fiscal yearFY2025FY2024FY2024FY2023FY2023
Revenue$0$0n/a$0n/a
Net income-$30.1M-$21.7M-$8.3M-$29.3M-$14.6M
Diluted EPS-$0.63-$1.21n/a-$2.47n/a
Operating cash flow-$27.6M-$14.7M-$7.2M-$12.0M-$11.9M
Cash and equivalents$3.6M$12.7M$4.9M$3.7M$1.5M
Total assets$27.4M$20.0M$6.2M$4.4M$4.0M
Total liabilities$6.4M$5.4M$2.4M$5.9M$3.2M
Shareholders' equity$20.9M$14.6M$3.8M-$1.6M$731K

As TuHURA Biosciences, Inc./NV tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Mar 31, 2026 ↗

Stock Splits

Every split and reverse split in the price history
  • 1-for-35Reverse splitOct 18, 2024
  • 1-for-50Reverse splitNov 14, 2022
  • 1-for-10Reverse splitMay 8, 2019
  • 1-for-4Reverse splitMay 20, 2016

Split dates and ratios from the price history · Close Prices from Tiingo.com

Material Events (8-K)

Corporate events filed with the SEC
  • 8-K · Items 2.03, 9.01Direct financial obligationNov 18, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsNov 13, 2026
    EDGAR ↗
  • 8-K · Items 2.03, 9.01Direct financial obligationNov 6, 2026
    EDGAR ↗
  • 8-K · Items 2.03, 9.01Direct financial obligationOct 16, 2026
    EDGAR ↗
  • 8-K · Items 2.03, 9.01Direct financial obligationSep 24, 2026
    EDGAR ↗
  • 8-K · Items 2.03, 9.01Direct financial obligationSep 17, 2026
    EDGAR ↗
  • 8-K/A · Items 5.02, 9.01Officer / director changeSep 17, 2026
    EDGAR ↗
  • 8-K · Items 5.02, 9.01Officer / director changeSep 16, 2026
    EDGAR ↗
  • 8-K · Items 2.03, 9.01Direct financial obligationSep 4, 2026
    EDGAR ↗
  • 8-K · Items 2.03, 9.01Direct financial obligationAug 21, 2026
    EDGAR ↗

About TuHURA Biosciences, Inc./NV

From SEC EDGAR company records
Industry (SIC 2834)Pharmaceutical Preparations
SectorHealthcare
HeadquartersTAMPA, FL
IncorporatedNV
Former namesKintara Therapeutics, Inc., DelMar Pharmaceuticals, Inc., Berry Only Inc.